Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The macroenviromental control of cancer metabolism by p62.

Huang J, Diaz-Meco MT, Moscat J.

Cell Cycle. 2018;17(17):2110-2121. doi: 10.1080/15384101.2018.1520566. Epub 2018 Sep 20.

PMID:
30198373
2.

Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor.

Huang J, Duran A, Reina-Campos M, Valencia T, Castilla EA, Müller TD, Tschöp MH, Moscat J, Diaz-Meco MT.

Cancer Cell. 2018 Apr 9;33(4):770-784.e6. doi: 10.1016/j.ccell.2018.03.001.

3.

Metabolic reprogramming of the tumor microenvironment by p62 and its partners.

Reina-Campos M, Shelton PM, Diaz-Meco MT, Moscat J.

Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):88-95. doi: 10.1016/j.bbcan.2018.04.010. Epub 2018 Apr 25. Review.

PMID:
29702207
4.

The role of adipose tissue in cancer-associated cachexia.

Vaitkus JA, Celi FS.

Exp Biol Med (Maywood). 2017 Mar;242(5):473-481. doi: 10.1177/1535370216683282. Epub 2016 Dec 8. Review.

5.

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma.

Nakagawa H, Hayata Y, Kawamura S, Yamada T, Fujiwara N, Koike K.

Cancers (Basel). 2018 Nov 15;10(11). pii: E447. doi: 10.3390/cancers10110447. Review.

6.
7.

Lipid metabolism in cancer cachexia.

Dalal S.

Ann Palliat Med. 2019 Jan;8(1):13-23. doi: 10.21037/apm.2018.10.01. Epub 2018 Oct 30.

8.

Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice.

Kliewer KL, Ke JY, Tian M, Cole RM, Andridge RR, Belury MA.

Cancer Biol Ther. 2015;16(6):886-97. doi: 10.4161/15384047.2014.987075. Epub 2014 Dec 2.

9.

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.

Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, Mehla K, Pipinos II, Powers R, Yu F, Singh PK.

Cancer Metab. 2014 Sep 1;2:18. doi: 10.1186/2049-3002-2-18. eCollection 2014. Erratum in: Cancer Metab. 2014;2:22.

10.

Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia.

Tsoli M, Swarbrick MM, Robertson GR.

Semin Cell Dev Biol. 2016 Jun;54:68-81. doi: 10.1016/j.semcdb.2015.10.039. Epub 2015 Oct 31. Review.

PMID:
26529279
11.

p62 at the interface of autophagy, oxidative stress signaling, and cancer.

Nezis IP, Stenmark H.

Antioxid Redox Signal. 2012 Sep 1;17(5):786-93. doi: 10.1089/ars.2011.4394. Epub 2012 Jan 11. Review.

PMID:
22074114
12.

Regulation of adipose tissue metabolism in cancer cachexia.

Bing C, Trayhurn P.

Curr Opin Clin Nutr Metab Care. 2008 May;11(3):201-7. doi: 10.1097/MCO.0b013e3282f948e2. Review.

PMID:
18403913
13.

Dietary lipids and adipocytes: potential therapeutic targets in cancers.

Kwan HY, Chao X, Su T, Fu XQ, Liu B, Tse AK, Fong WF, Yu ZL.

J Nutr Biochem. 2015 Apr;26(4):303-11. doi: 10.1016/j.jnutbio.2014.11.001. Epub 2014 Dec 3. Review.

PMID:
25524629
14.

Metabolic remodeling induced by adipocytes: a new Achilles' heel in invasive breast cancer?

Attane C, Milhas D, Hoy AJ, Muller C.

Curr Med Chem. 2018 Apr 26. doi: 10.2174/0929867325666180426165001. [Epub ahead of print]

PMID:
29708068
15.

p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system.

Xia M, Yu H, Gu S, Xu Y, Su J, Li H, Kang J, Cui M.

Int J Oncol. 2014 Dec;45(6):2341-8. doi: 10.3892/ijo.2014.2669. Epub 2014 Sep 24.

PMID:
25269472
16.

p62 links β-adrenergic input to mitochondrial function and thermogenesis.

Müller TD, Lee SJ, Jastroch M, Kabra D, Stemmer K, Aichler M, Abplanalp B, Ananthakrishnan G, Bhardwaj N, Collins S, Divanovic S, Endele M, Finan B, Gao Y, Habegger KM, Hembree J, Heppner KM, Hofmann S, Holland J, Küchler D, Kutschke M, Krishna R, Lehti M, Oelkrug R, Ottaway N, Perez-Tilve D, Raver C, Walch AK, Schriever SC, Speakman J, Tseng YH, Diaz-Meco M, Pfluger PT, Moscat J, Tschöp MH.

J Clin Invest. 2013 Jan;123(1):469-78. doi: 10.1172/JCI64209. Epub 2012 Dec 21.

17.

Activation of p62/SQSTM1-Keap1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Cancer.

Ichimura Y, Komatsu M.

Front Oncol. 2018 Jun 7;8:210. doi: 10.3389/fonc.2018.00210. eCollection 2018. Review.

18.

p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.

Saito T, Ichimura Y, Taguchi K, Suzuki T, Mizushima T, Takagi K, Hirose Y, Nagahashi M, Iso T, Fukutomi T, Ohishi M, Endo K, Uemura T, Nishito Y, Okuda S, Obata M, Kouno T, Imamura R, Tada Y, Obata R, Yasuda D, Takahashi K, Fujimura T, Pi J, Lee MS, Ueno T, Ohe T, Mashino T, Wakai T, Kojima H, Okabe T, Nagano T, Motohashi H, Waguri S, Soga T, Yamamoto M, Tanaka K, Komatsu M.

Nat Commun. 2016 Jun 27;7:12030. doi: 10.1038/ncomms12030.

19.

Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways.

Cai-McRae X, Zhong H, Karantza V.

Oncogene. 2015 Jun 4;34(23):2968-77. doi: 10.1038/onc.2014.244. Epub 2014 Aug 4.

PMID:
25088198
20.

Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.

Lengyel E, Makowski L, DiGiovanni J, Kolonin MG.

Trends Cancer. 2018 May;4(5):374-384. doi: 10.1016/j.trecan.2018.03.004. Epub 2018 Apr 5. Review.

PMID:
29709261

Supplemental Content

Support Center